Anergis raised €14M in a Series A round in Mar 2011. The company is based in Epalinges, Switzerland. Investors in the round: BioMed Partners, Sunstone Capital, Vinci Capital. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
